Registration Strip Icon for discussion Registrati per interagire nei nostri forum attivi per discutere con investitori con idee simili.

EVFM

Evofem Biosciences (QB) (EVFM)

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:USOTC:EVFM
DataOraFonteTitoloSimboloCompagnia
15/05/202412:50Edgar (US Regulatory)Form 8-K - Current reportUSOTC:EVFMEvofem Biosciences Inc (QB)
15/05/202412:45Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]USOTC:EVFMEvofem Biosciences Inc (QB)
14/02/202420:14Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]USOTC:EVFMEvofem Biosciences Inc (QB)
25/01/202422:23Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]USOTC:EVFMEvofem Biosciences Inc (QB)
12/01/202423:13Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:EVFMEvofem Biosciences Inc (QB)
29/08/202322:00Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsUSOTC:EVFMEvofem Biosciences Inc (QB)
18/08/202322:08Edgar (US Regulatory)Form PRER14A - Preliminary Proxy Soliciting materialsUSOTC:EVFMEvofem Biosciences Inc (QB)
15/08/202306:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessUSOTC:EVFMEvofem Biosciences Inc (QB)
14/08/202323:24Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]USOTC:EVFMEvofem Biosciences Inc (QB)
03/08/202323:31Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]USOTC:EVFMEvofem Biosciences Inc (QB)
16/06/202323:01Edgar (US Regulatory)Quarterly Report (10-q)USOTC:EVFMEvofem Biosciences Inc (QB)
16/06/202322:02Edgar (US Regulatory)Current Report Filing (8-k)USOTC:EVFMEvofem Biosciences Inc (QB)
12/05/202322:16Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)USOTC:EVFMEvofem Biosciences Inc (QB)
27/04/202323:29Edgar (US Regulatory)Annual Report (10-k)USOTC:EVFMEvofem Biosciences Inc (QB)
12/04/202312:02Edgar (US Regulatory)Amended Current Report Filing (8-k/a)USOTC:EVFMEvofem Biosciences Inc (QB)
31/03/202322:03Edgar (US Regulatory)Notification That Annual Report Will Be Submitted Late (nt 10-k)USOTC:EVFMEvofem Biosciences Inc (QB)
06/03/202320:49Edgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)USOTC:EVFMEvofem Biosciences Inc (QB)
15/02/202322:01Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)USOTC:EVFMEvofem Biosciences Inc (QB)
27/01/202312:05Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)USOTC:EVFMEvofem Biosciences Inc (QB)
03/10/202212:49Edgar (US Regulatory)Notice of Effectiveness (effect)USOTC:EVFMEvofem Biosciences Inc (QB)
30/09/202222:13Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)USOTC:EVFMEvofem Biosciences Inc (QB)
23/09/202223:06Edgar (US Regulatory)Securities Registration Statement (s-1)USOTC:EVFMEvofem Biosciences Inc (QB)
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:USOTC:EVFM
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network